Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) reported data showing that its drug vutrisiran reduced gastrointestinal events in patients with transthyretin-mediated amyloid ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE